The shares of AAA Pharmaceuticals Limited made a lifetime high at $265. A week later, the company recently received a US FDA warning letter regarding deficiencies observed in the company's drugs manufacturing processes. As a result, the shares of the company crashed and currently trade at around $120. Ankit Vishnu, a retail investor who tracks the company's shares, made the following comment:"The share’s price dropped from a lifetime high of $265 to $120, a drop of 55%. This makes the stock a strong ‘buy’."The behavioral bias exhibited by Vishnu is the: